Cargando…

1011. Sepsis and Secondary Hemophagocytic Lymphohistiocytosis

BACKGROUND: Hemophagocytic lymphohistiocytosis (HLH) is a life-threatening hyperinflammatory condition diagnosed by HLH 2004 criteria. This criterion has common clinical and laboratory features with sepsis and tropical fevers, but there is marked difference in management and outcome of these two ent...

Descripción completa

Detalles Bibliográficos
Autores principales: Fazal, Farhan, Wig, Naveet, Soneja, Manish, Mitra, Dipendra K, Panda, Sk, Satpathy, Gita, Vikram, Naval Kishore, Pandey, R M, Chaturvedi, P K
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6254891/
http://dx.doi.org/10.1093/ofid/ofy210.848
_version_ 1783373830620708864
author Fazal, Farhan
Wig, Naveet
Soneja, Manish
Mitra, Dipendra K
Panda, Sk
Satpathy, Gita
Vikram, Naval Kishore
Pandey, R M
Chaturvedi, P K
author_facet Fazal, Farhan
Wig, Naveet
Soneja, Manish
Mitra, Dipendra K
Panda, Sk
Satpathy, Gita
Vikram, Naval Kishore
Pandey, R M
Chaturvedi, P K
author_sort Fazal, Farhan
collection PubMed
description BACKGROUND: Hemophagocytic lymphohistiocytosis (HLH) is a life-threatening hyperinflammatory condition diagnosed by HLH 2004 criteria. This criterion has common clinical and laboratory features with sepsis and tropical fevers, but there is marked difference in management and outcome of these two entities. The study is conducted to know whether there is any difference in the clinico-laboratory features, management, and outcome of sepsis with or without secondary HLH. METHODS: This is a prospective observational study where patients presenting with sepsis and bicytopenia are included. The patients underwent relevant investigations according to 2004 HLH diagnostic criteria. The patients are divided into sepsis with or without HLH. The underlying etiology, treatment, and outcome of the two groups are analysed. RESULTS: Fifty sepsis patients are included in the study, out of which 28 fulfilled the HLH diagnostic criteria which comprised of 18 men and 10 women. The etiology were bacterial (three enteric fever, three tuberculosis, two scrub typhus, one Staphylococcal aureus), viral (one dengue fever, two HIV, two encephalitis), fungal (one aspergillosis, one mucormycosis, two others), parasites (three malaria, one leishmania) malignancy (two hodgkin lymphoma, one non-Hodgkins lymphoma), and unknown etiology in six patients, with >1 etiology in three patients (Figure 2). The percentage of each criterion fulfilled in both groups is given in Figure 1, showing an increased occurrence of splenomegaly, low NK cell activity, hypertriglyceridemia in HLH patients. Steroids along with supportive treatment was given to 53% and etoposide was added in 7%. Treatment for underlying etiology alone without immunosuppressive treatment was given in 39%. The mortality in those with HLH vs. without HLH was 42% and 31%, respectively. The median duration of hospital stay was 18 and 36 days in HLH and without HLH group, respectively. CONCLUSION: HLH should be suspected in sepsis patients with bicytopenia specially in tropical fevers. There is increased mortality if the sepsis patients fulfil HLH criteria. Early diagnosis and management is of paramount importance. DISCLOSURES: All authors: No reported disclosures.
format Online
Article
Text
id pubmed-6254891
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-62548912018-11-28 1011. Sepsis and Secondary Hemophagocytic Lymphohistiocytosis Fazal, Farhan Wig, Naveet Soneja, Manish Mitra, Dipendra K Panda, Sk Satpathy, Gita Vikram, Naval Kishore Pandey, R M Chaturvedi, P K Open Forum Infect Dis Abstracts BACKGROUND: Hemophagocytic lymphohistiocytosis (HLH) is a life-threatening hyperinflammatory condition diagnosed by HLH 2004 criteria. This criterion has common clinical and laboratory features with sepsis and tropical fevers, but there is marked difference in management and outcome of these two entities. The study is conducted to know whether there is any difference in the clinico-laboratory features, management, and outcome of sepsis with or without secondary HLH. METHODS: This is a prospective observational study where patients presenting with sepsis and bicytopenia are included. The patients underwent relevant investigations according to 2004 HLH diagnostic criteria. The patients are divided into sepsis with or without HLH. The underlying etiology, treatment, and outcome of the two groups are analysed. RESULTS: Fifty sepsis patients are included in the study, out of which 28 fulfilled the HLH diagnostic criteria which comprised of 18 men and 10 women. The etiology were bacterial (three enteric fever, three tuberculosis, two scrub typhus, one Staphylococcal aureus), viral (one dengue fever, two HIV, two encephalitis), fungal (one aspergillosis, one mucormycosis, two others), parasites (three malaria, one leishmania) malignancy (two hodgkin lymphoma, one non-Hodgkins lymphoma), and unknown etiology in six patients, with >1 etiology in three patients (Figure 2). The percentage of each criterion fulfilled in both groups is given in Figure 1, showing an increased occurrence of splenomegaly, low NK cell activity, hypertriglyceridemia in HLH patients. Steroids along with supportive treatment was given to 53% and etoposide was added in 7%. Treatment for underlying etiology alone without immunosuppressive treatment was given in 39%. The mortality in those with HLH vs. without HLH was 42% and 31%, respectively. The median duration of hospital stay was 18 and 36 days in HLH and without HLH group, respectively. CONCLUSION: HLH should be suspected in sepsis patients with bicytopenia specially in tropical fevers. There is increased mortality if the sepsis patients fulfil HLH criteria. Early diagnosis and management is of paramount importance. DISCLOSURES: All authors: No reported disclosures. Oxford University Press 2018-11-26 /pmc/articles/PMC6254891/ http://dx.doi.org/10.1093/ofid/ofy210.848 Text en © The Author(s) 2018. Published by Oxford University Press on behalf of Infectious Diseases Society of America. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Abstracts
Fazal, Farhan
Wig, Naveet
Soneja, Manish
Mitra, Dipendra K
Panda, Sk
Satpathy, Gita
Vikram, Naval Kishore
Pandey, R M
Chaturvedi, P K
1011. Sepsis and Secondary Hemophagocytic Lymphohistiocytosis
title 1011. Sepsis and Secondary Hemophagocytic Lymphohistiocytosis
title_full 1011. Sepsis and Secondary Hemophagocytic Lymphohistiocytosis
title_fullStr 1011. Sepsis and Secondary Hemophagocytic Lymphohistiocytosis
title_full_unstemmed 1011. Sepsis and Secondary Hemophagocytic Lymphohistiocytosis
title_short 1011. Sepsis and Secondary Hemophagocytic Lymphohistiocytosis
title_sort 1011. sepsis and secondary hemophagocytic lymphohistiocytosis
topic Abstracts
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6254891/
http://dx.doi.org/10.1093/ofid/ofy210.848
work_keys_str_mv AT fazalfarhan 1011sepsisandsecondaryhemophagocyticlymphohistiocytosis
AT wignaveet 1011sepsisandsecondaryhemophagocyticlymphohistiocytosis
AT sonejamanish 1011sepsisandsecondaryhemophagocyticlymphohistiocytosis
AT mitradipendrak 1011sepsisandsecondaryhemophagocyticlymphohistiocytosis
AT pandask 1011sepsisandsecondaryhemophagocyticlymphohistiocytosis
AT satpathygita 1011sepsisandsecondaryhemophagocyticlymphohistiocytosis
AT vikramnavalkishore 1011sepsisandsecondaryhemophagocyticlymphohistiocytosis
AT pandeyrm 1011sepsisandsecondaryhemophagocyticlymphohistiocytosis
AT chaturvedipk 1011sepsisandsecondaryhemophagocyticlymphohistiocytosis